Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure EC Perin, HFR Dohmann, R Borojevic, SA Silva, ALS Sousa, CT Mesquita, ... Circulation 107 (18), 2294-2302, 2003 | 1995 | 2003 |
Adult bone marrow–derived cells for cardiac repair: a systematic review and meta-analysis A Abdel-Latif, R Bolli, IM Tleyjeh, VM Montori, EC Perin, CA Hornung, ... Archives of internal medicine 167 (10), 989-997, 2007 | 1214 | 2007 |
Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model GV Silva, S Litovsky, JAR Assad, ALS Sousa, BJ Martin, D Vela, ... Circulation 111 (2), 150-156, 2005 | 1124 | 2005 |
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the … EC Perin, JT Willerson, CJ Pepine, TD Henry, SG Ellis, DXM Zhao, ... Jama 307 (16), 1717-1726, 2012 | 543 | 2012 |
Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy EC Perin, HFR Dohmann, R Borojevic, SA Silva, ALS Sousa, GV Silva, ... Circulation 110 (11_suppl_1), II-213-II-218, 2004 | 509 | 2004 |
Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME … JH Traverse, TD Henry, SG Ellis, CJ Pepine, JT Willerson, DXM Zhao, ... Jama 306 (19), 2110-2119, 2011 | 467 | 2011 |
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial JH Traverse, TD Henry, CJ Pepine, JT Willerson, DXM Zhao, SG Ellis, ... Jama 308 (22), 2380-2389, 2012 | 465 | 2012 |
Anomalous coronary arteries: angiographic findings in 80 patients O Topaz, EJ DeMarchena, E Perin, LS Sommer, SM Mallon, RA Chahine International journal of cardiology 34 (2), 129-138, 1992 | 336 | 1992 |
Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial EC Perin, R Sanz-Ruiz, PL Sánchez, J Lasso, R Pérez-Cano, ... American heart journal 168 (1), 88-95. e2, 2014 | 330 | 2014 |
Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction EC Perin, GV Silva, JAR Assad, D Vela, LM Buja, ALS Sousa, S Litovsky, ... Journal of molecular and cellular cardiology 44 (3), 486-495, 2008 | 305 | 2008 |
Adult stem cell therapy in perspective EC Perin, YJ Geng, JT Willerson Circulation 107 (7), 935-938, 2003 | 244 | 2003 |
A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF) EC Perin, GV Silva, TD Henry, MG Cabreira-Hansen, WH Moore, ... American heart journal 161 (6), 1078-1087. e3, 2011 | 218 | 2011 |
A phase II dose-escalation study of allogeneic mesenchymal precursor cells in patients with ischemic or nonischemic heart failure EC Perin, KM Borow, GV Silva, AN DeMaria, OC Marroquin, PP Huang, ... Circulation research 117 (6), 576-584, 2015 | 210 | 2015 |
Assessing myocardial viability and infarct transmurality with left ventricular electromechanical mapping in patients with stable coronary artery disease: validation by delayed … EC Perin, GV Silva, R Sarmento-Leite, ALS Sousa, M Howell, ... Circulation 106 (8), 957-961, 2002 | 195 | 2002 |
CD34+ cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent AA Quyyumi, EK Waller, J Murrow, F Esteves, J Galt, J Oshinski, S Lerakis, ... American heart journal 161 (1), 98-105, 2011 | 177 | 2011 |
Global position paper on cardiovascular regenerative medicine F Fernández-Avilés, R Sanz-Ruiz, AM Climent, L Badimon, R Bolli, ... European heart journal 38 (33), 2532-2546, 2017 | 147 | 2017 |
Concise review: review and perspective of cell dosage and routes of administration from preclinical and clinical studies of stem cell therapy for heart disease S Golpanian, IH Schulman, RF Ebert, AW Heldman, DL DiFede, PC Yang, ... Stem cells translational medicine 5 (2), 186-191, 2016 | 136 | 2016 |
Methods of stem cell delivery in cardiac diseases EC Perin, J López Nature Clinical Practice Cardiovascular Medicine 3 (Suppl 1), S110-S113, 2006 | 131 | 2006 |
Transendocardial autologous bone marrow mononuclear cell injection in ischemic heart failure: postmortem anatomicopathologic and immunohistochemical findings HFR Dohmann, EC Perin, CM Takiya, GV Silva, SA Silva, ALS Sousa, ... Circulation 112 (4), 521-526, 2005 | 127 | 2005 |
The Athena trials: Autologous adipose‐derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction TD Henry, CJ Pepine, CR Lambert, JH Traverse, R Schatz, M Costa, ... Catheterization and Cardiovascular Interventions 89 (2), 169-177, 2017 | 124 | 2017 |